| Bioactivity | (R)-Tegoprazan (example 3), a benzimidazole derivative, is a potent kidney H+/K+-ATPase inhibitor with an IC50 of 98 nM of canine kidney Na+/K+-ATPase. (R)-Tegoprazan has the potential for gastrointestinal diseases research[1]. | ||||||||||||
| Name | (R)-Tegoprazan | ||||||||||||
| CAS | 942195-56-4 | ||||||||||||
| Formula | C20H19F2N3O3 | ||||||||||||
| Molar Mass | 387.38 | ||||||||||||
| Appearance | Solid | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. Takeshi Hanazawa, et al. Chromane Substituted Benzimidazole Derivatives. US20070142448A1. |
(R)-Tegoprazan
CAS: 942195-56-4 F: C20H19F2N3O3 W: 387.38
(R)-Tegoprazan (example 3), a benzimidazole derivative, is a potent kidney H+/K+-ATPase inhibitor with an IC50 of 98 nM
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.